3,3'-diaminobenzidine has been researched along with Lymphoma, Large B-Cell, Diffuse in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anan, T; Higashi, M; Kikuchi, J; Kizaki, M; Momose, S; Takayanagi, N; Tamaru, JI; Tanaka, Y; Tokuhira, M; Yamashita, T | 1 |
1 other study(ies) available for 3,3'-diaminobenzidine and Lymphoma, Large B-Cell, Diffuse
| Article | Year |
|---|---|
Fluorescent nanoparticle-mediated semiquantitative MYC protein expression analysis in morphologically diffuse large B-cell lymphoma.
Topics: 3,3'-Diaminobenzidine; Adult; Aged; Female; Gene Rearrangement; Humans; Immunohistochemistry; In Situ Hybridization, Fluorescence; Luminescent Agents; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Nanoparticles; Prognosis; Proto-Oncogene Proteins c-myc; Young Adult | 2021 |